2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol

Catalog No. :
ACVJTS827
CAS No. :
103788-65-4
Molecular Formula :
C12H13NO2
Molecular Weight :
203.24

IUPAC Name:2-(5-methyl-2-phenyloxazol-4-yl)ethan-1-ol

2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$87.00Login to see priceInquiryInquiry
5g95%$330.00Login to see priceInquiryInquiry
10g95%$594.00Login to see priceInquiryInquiry
25g95%$1443.00Login to see priceInquiryInquiry
50g95%$2804.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol
IUPAC Name2-(5-methyl-2-phenyloxazol-4-yl)ethan-1-ol
MDL No.MFCD00100006
Molecular FormulaC12H13NO2
Molecular Weight203.24
SMILESCC1=C(CCO)N=C(O1)C1=CC=CC=C1
InChI KeyJYWHQBLLIBQGCU-UHFFFAOYSA-N
SynonymMaybridge3_000599 | MFCD00100006 | 2-(5-methyl-2-phenyl-oxazol-4-yl)ethanol | 2-(5-methyl-2-phenyl-oxazol-4-yl)-ethanol | 2-(5-Methyl-2-phenyloxazol-4-yl)ethanol | 2-(5-methyl-2-phenyloxazol-4-yl)-ethanol | AM802863 | CCG-235167 | 2-(5-methyl-2-phenyl-1,3
CAS No.103788-65-4
PubChem CID725585

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P280-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVJTS827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVJTS827 route product structure diagram
    ACVJTS827103788-65-4
Inquiry

2. ACVJTS827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVJTS827 route product structure diagram
    ACVJTS827103788-65-4
Inquiry

Comments (0)